Number of the records: 1  

Inhibítory PCSK9 a postavenie evolokumabu v liečbe pacientov s hyperlipoproteinémiou

  1. TitleInhibítory PCSK9 a postavenie evolokumabu v liečbe pacientov s hyperlipoproteinémiou
    Par.titlePCSK9 inhibitors and the role of evolocumab in the therapy for patients with hyperlipoproteinemia
    Author infoAndrej Dukát ... [et al.]
    Co-authors Dukát Andrej 1950-
    Kriška Milan 1940-
    Sabaka Peter
    Gavorník Peter 1948-2022
    Kužma Martin
    Payer Juraj 1958-
    NoteBibliogr. odkazy. - Res. angl., slov.
    Sign.C 3133
    Source Forum diabetologicum. - ISSN 1805-3807. - Brno : Facta Medica , 2018 . - Roč. 7, č. 1 (2018), s. 71-75  : ilustr., tab.
    LanguageSlovak
    CountryCzech Republic
    Document kindRozpis článkov z periodík
    DatabaseARTICLES
    article

    article

Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.